In 1982 Genentech received approval to launch a recombinant DNA human insulin product, completely doing away with the conventional method of using a pancreatic extract taken from swine.
1982 年，基因科技利用基因重組生產出來的人類胰島素獲准上市，完全取代了從豬胰臟分離而來的胰島素。